Cancer Cell
Volume 33, Issue 3, 12 March 2018, Pages 495-511.e12
ArticleORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Under an Elsevier user license
open archive
Keywords
ORY-1001
KDM1A
LSD1
acute myeloid leukemia
epigenetic
histone methylation
differentiation
Cited by (0)
- 6
Lead Contact
© 2018 Elsevier Inc.